Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFWM
2501
DELISTED
First Foundation Inc
FFWM
| $2.87M | ﹤0.01% |
553,063
-61,084
| -10% | -$328K |
|
2502
RCI Hospitality Holdings
RICK
$201M
| $2.87M | ﹤0.01% |
66,810
-1,260
| -2% | -$64.3K |
|
2503
AnaptysBio
ANAB
$1.62B
| $2.85M | ﹤0.01% |
153,356
-12,698
| -8% | -$212K |
|
2504
Clearfield
CLFD
$363M
| $2.85M | ﹤0.01% |
95,825
+4,290
| +5% | +$143K |
|
2505
Nomura Holdings
NMR
$29B
| $2.85M | ﹤0.01% |
462,647
+80,540
| +21% | +$513K |
|
2506
Emergent Biosolutions
EBS
$272M
| $2.83M | ﹤0.01% |
583,271
-706,959
| -55% | -$5.85M |
|
2507
Lindblad Expeditions
LIND
$2.23B
| $2.82M | ﹤0.01% |
304,293
-7,590
| -2% | -$86.6K |
|
2508
argenx
ARGX
$54.8B
| $2.8M | ﹤0.01% |
4,732
+518
| +12% | +$327K |
|
2509
Innodata
INOD
$2.14B
| $2.8M | ﹤0.01% |
77,863
+1,852
| +2% | +$81.4K |
|
2510
indie Semiconductor
INDI
$725M
| $2.79M | ﹤0.01% |
1,371,117
-59,976
| -4% | -$209K |
|
2511
Relay Therapeutics
RLAY
$4.3B
| $2.79M | ﹤0.01% |
1,064,858
+54,051
| +5% | +$212K |
|
|
CLDT
2512
Chatham Lodging
CLDT
$607M
| $2.79M | ﹤0.01% |
391,037
-111,169
| -22% | -$921K |
|
|
GOGL
2513
DELISTED
Golden Ocean Group
GOGL
| $2.79M | ﹤0.01% |
349,159
-4,075
| -1% | -$36.2K |
|
2514
ENI
E
$78.5B
| $2.78M | ﹤0.01% |
89,941
+36,933
| +70% | +$1.08M |
|
2515
8x8 Inc
EGHT
$328M
| $2.77M | ﹤0.01% |
1,382,628
-36,115
| -3% | -$93.1K |
|
2516
Ameresco
AMRC
$1.36B
| $2.76M | ﹤0.01% |
228,222
-47,738
| -17% | -$865K |
|
2517
IMAX
IMAX
$2.73B
| $2.75M | ﹤0.01% |
104,510
+1,309
| +1% | +$32.7K |
|
2518
Vanguard Information Technology ETF
VGT
$147B
| $2.72M | ﹤0.01% |
40,184
-4,672
| -10% | -$352K |
|
|
PLGO
2519
Pelagos Insurance Capital
PLGO
$2.18B
| $2.69M | ﹤0.01% |
166,257
+43,038
| +35% | +$688K |
|
2520
Bank of Marin Bancorp
BMRC
$465M
| $2.69M | ﹤0.01% |
121,721
+954
| +0.8% | +$22.6K |
|
2521
NerdWallet
NRDS
$582M
| $2.67M | ﹤0.01% |
295,240
-3,724
| -1% | -$44.6K |
|
2522
Funko
FNKO
$295M
| $2.66M | ﹤0.01% |
387,570
-48,985
| -11% | -$569K |
|
2523
Xperi
XPER
$331M
| $2.66M | ﹤0.01% |
344,320
-105,121
| -23% | -$919K |
|
2524
Savara
SVRA
$1.19B
| $2.64M | ﹤0.01% |
954,830
-8,991
| -0.9% | -$24.8K |
|
2525
Standard BioTools
LAB
$314M
| $2.64M | ﹤0.01% |
2,443,060
+110,411
| +5% | +$155K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.